Lp(a): Assessing and Treating a Major Source of Atherosclerosis - CME Recording
Dr. Trippi and Dr. Brown give a short introduction of the current understanding of Lp(a) patho-physiology, a discussion of treatment options at present, a thorough discussion of how lipoprotein apheresis fits into the treatment landscape, two case histories of patients receiving lipoprotein apheresis for increased Lp(a) and a short discussion of medications in development for the treatment of Lp(a).
▶︎
LDL Cholesterol: How Low is too Low?
▶︎
Update on the management of elevated Lp(a) - CME
▶︎
Lp(a): What We Should Know; Need to Know; and Hope to Know - CME
▶︎
Professor Steven Nissen - Lipoprotein(a): a new target for therapeutic intervention
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Lp(a) Explained: Genetics, Risk, and What You Can Actually Do
▶︎
Lp(a): A Challenge in Diagnosis and Treatments - CME Recording
▶︎
APO B & LpA l Dr. Paul Thompson
▶︎
Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019
▶︎
Lipoprotein(a): What Clinicians Should Know
▶︎
2020 FH Global Summit Session 4: Lp(a) and Drivers of Inherited Risk
▶︎
Managing Nephrology Patients
▶︎
Webcast: Clinical Tipping Points In Portal Hypertension Virtual Broadcast
▶︎
2026 Spring Clinical Meetings Achieving Success in Heart Failure Updates in the Management of Car
▶︎
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
▶︎
2-9-2023 - Updates on Lipid Management: New Tools in the New Era
▶︎
Cholesterol: The Good, The Bad, and Lipoprotein (a)
▶︎
Elevated Lipoprotein “little a”. What's the best treatment for Lp(a)?
▶︎
Managing PAD in Patients with FH and Lp(a): Insights from Two Clinical Cases - CME Recording
▶︎